Morningstar issued a Zimmer Biomet a BBB+ credit rating, according to Dakota Financial News.
Here are four facts:
1. The credit rating indicates the company is a moderate default risk.
2. Morningstar also gave Zimmer Biomet stock a four-star rating.
3. Zimmer Biomet has a 50-day moving average of $100.96 and a 200-day moving average of $109.45.
4. The company has a market cap of $19.07 billion and a P/E ratio of 47.61.
More articles on devices:
Materialise, Lima partner on total knee replacements: 5 things to know
MedTorque releases new handle ratcheting for orthopedics, spine: 5 things to know
K2M commercially launches deformity spinal system in the US: 5 key notes